Incorporation of inhaled insulin into the FDA accepted University of Virginia/Padova Type 1 Diabetes Simulator. - Roberto Visentin; Thomas Klabunde; Marshall Grant; Chiara Dalla Man; Claudio Cobelli (EMBC, 2015)

One-Day Bayesian Cloning of Type 1 Diabetes Subjects: Toward a Single-Day UVA/Padova Type 1 Diabetes Simulator. - Roberto Visentin; Chiara Dalla Man; Claudio Cobelli (IEEE Trans. Biomed. Eng., 2016)

A Hybrid Clustering Prediction for Type 1 Diabetes Aid: Towards Decision Support Systems Based upon Scenario Profile Analysis. - Iván Contreras; Josep Vehí; Roberto Visentin; Martina Vettoretti (CHASE, 2017)

A Model of Acetaminophen Pharmacokinetics and its Effect on Continuous Glucose Monitoring Sensor Measurements. - Michele Schiavon; Giada Acciaroli; Martina Vettoretti; Alberto Giaretta 002; Roberto Visentin (EMBC, 2018)

Long-acting Insulin in Diabetes Therapy: In Silico Clinical Trials with the UVA/Padova Type 1 Diabetes Simulator*. - Roberto Visentin; Michele Schiavon; Clemens Giegerich; Thomas Klabunde; Chiara Dalla Man; Claudio Cobelli (EMBC, 2018)

Toward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results. - Chiara Toffanin; Roberto Visentin; Mirko Messori; Federico Di Palma; Lalo Magni; Claudio Cobelli (IEEE Trans. Biomed. Eng., 2018)

Incorporating Long-Acting Insulin Glargine Into the UVA/Padova Type 1 Diabetes Simulator for In Silico Testing of MDI Therapies. - Roberto Visentin; Michele Schiavon; Clemens Giegerich; Thomas Klabunde; Chiara Dalla Man; Claudio Cobelli (IEEE Trans. Biomed. Eng., 2019)

In Silico Cloning of Target Type 2 Diabetes Population for Treatments Development and Decision Support*. - Roberto Visentin; Michele Schiavon; Chiara Dalla Man (EMBC, 2020)

Modeling Subcutaneous Absorption of Long-Acting Insulin Glargine in Type 1 Diabetes. - Michele Schiavon; Roberto Visentin; Clemens Giegerich; Thomas Klabunde; Claudio Cobelli; Chiara Dalla Man (IEEE Trans. Biomed. Eng., 2020)

Modeling Pharmacokinetics of Doxorubicin in Multiple Myeloma Cells. - Alberto Giaretta 002; Francesco Da Ros; Mario Mazzucato; Morten Gram Pedersen; Roberto Visentin (EMBC, 2021)

A Novel Method for Generation of In Silico Subjects with Type 2 Diabetes. - Roberto Visentin; Mattia De Lazzari (EMBC, 2021)

Glucose Controlin Type 2 Diabetes: In Silico Study of Sub-Optimal Adherence to Insulin Therapy. - Roberto Visentin; Claudio Cobelli; Jochen Sieber; Chiara Dalla Man (ICSC, 2022)

A software interface for in silico testing of type 2 diabetes treatments. - Roberto Visentin; Claudio Cobelli; Chiara Dalla Man (Comput. Methods Programs Biomed., 2022)

Modeling Doxorubicin Pharmacokinetics in Multiple Myeloma Suggests Mechanism of Drug Resistance. - Roya Doshmanziari; Francesco Da Ros; Mario Mazzucato; Morten Gram Pedersen; Roberto Visentin (IEEE Trans. Biomed. Eng., 2024)

Tailoring the Padova Type 2 Diabetes Simulator for Treatment Guidance in Target Populations. - Roberto Visentin; Michele Schiavon; Jacopo Bonet; Michela Riz; Britta Wagenhuber; Chiara Dalla Man (IEEE Trans. Biomed. Eng., 2024)